Should I Buy CVRX? CVRX 2026 Analysis

Should You Buy CVRx Inc (CVRX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

6.550

1 Day change

-1.36%

52 Week Range

15.410

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: price is weak, catalysts are skewed negative into earnings, and there are no Intellectia buy signals.
If you already own it, this is more of a “hold/avoid adding” until it reclaims ~6.91 (pivot) and shows sustained strength above ~7.67 (R1).
Near-term trade setup is mostly a speculative dead-cat bounce near support (6.16–5.69), not a high-conviction entry.

Technical Analysis

Price: 6.43 (-8.62% today), trading below the pivot (6.911) and sitting close to S1 (6.155) → trend pressure remains bearish near-term.
RSI(6)=37.7: weak/near-oversold but not a clean reversal signal; suggests downside momentum is elevated but could stabilize near support.
MACD histogram +0.0833 but positively contracting: bullish impulse fading; consistent with a weak bounce losing steam.
Moving averages converging: compression/indecision; typically needs a breakout (above 6.91/7.67) to confirm trend change.
Key levels: Support 6.155 then 5.687; Resistance 6.911 then 7.667 (next 8.135). A break below 6.155 increases odds of revisiting ~5.69.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open interest put/call = 0.59: positioning leans bullish (more call OI than put OI).
Option volume is effectively 0 today: sentiment read is weak/illiquid in the tape (hard to trust as a real-time signal).
Very elevated volatility: IV 30d ~143.7 with IV percentile ~96.8 → market is pricing large moves (earnings/legal headline risk). That typically reduces the attractiveness of “buy now” stock entries for an impatient timeframe unless you’re explicitly trading a volatility event.

Technical Summary

Sell

Buy

Positive Catalysts

- Options open interest skew (PCR 0.
modestly favors calls (directionally supportive if fundamentals stabilize).

Neutral/Negative Catalysts

and disruptive territory manager turnover (May
were major prior drawdown drivers.
into potential securities law violations → headline risk and potential liability concerns.

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: 14.69M, +9.85% YoY → growth exists but not accelerating enough to override execution concerns.
Profitability: Net income -12.87M (more negative YoY) and EPS -0.49 (down 14.04% YoY) → losses remain sizable and trending worse on a per-share basis.
Gross margin: 86.81% (+4.35% YoY) → strong unit economics, but operating execution/scale is still the key problem.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend (latest provided: 2025-11-06): both Canaccord (PT raised to $11, Buy) and Cantor Fitzgerald (PT raised to $13, Overweight) increased targets after Q3 strength.
Wall Street pros: improving salesforce productivity narrative, strong gross margins, and potential operating leverage if revenue ramps.
Wall Street cons: execution risk (salesforce churn/territory changes), ongoing losses, and the new legal-investigation headline risk that can cap multiples and pressure sentiment.
Net: analyst targets are supportive on paper, but they are dated versus the newest negative catalysts, so they’re not enough to make this a “buy now.”

5 Analyst Rating

Wall Street analysts forecast CVRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVRX is 12.67 USD with a low forecast of 11 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

0 Hold

0 Sell

Strong Buy

Current: 6.640

Low

Averages

12.67

High

Current: 6.640

Low

Averages

12.67

High

Canaccord

Buy

upgrade

$9 -> $11

AI Analysis

2025-11-06

Reason

Canaccord

Price Target

$9 -> $11

AI Analysis

2025-11-06

upgrade

Buy

Reason

Canaccord raised the firm's price target on CVRx to $11 from $9 and keeps a Buy rating on the shares. The firm said they reported Q3 results ahead of expectations and they believe that the company is beginning to become confident about its rep hires beginning to become productive, which it attributed to the Q3 performance but still expects the bulk of the benefit to be realized in 2026.

Cantor Fitzgerald

Ross Osborn

Overweight

maintain

$11 -> $13

2025-11-06

Reason

Cantor Fitzgerald

Ross Osborn

Price Target

$11 -> $13

2025-11-06

maintain

Overweight

Reason

Cantor Fitzgerald analyst Ross Osborn raised the firm's price target on CVRx to $13 from $11 and keeps an Overweight rating on the shares. The company reported "strong" Q3 operating results and narrowing guidance, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CVRX

Unlock Now

CVRX Should I Buy

CVRX Should I Buy

Should You Buy CVRx Inc (CVRX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch